A. Benjamin Suttle
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 27
- Pancreatic and Hepatic Oncology Research 13
- Cancer Treatment and Pharmacology 9
- Colorectal Cancer Treatments and Studies 7
- HER2/EGFR in Cancer Research 5
-
- Lung Cancer Treatments and Mutations 10
- Renal cell carcinoma treatment 8
- Co-authors
- Jeffrey P. Hodge (8 shared papers)Lini Pandite (4 shared papers)Afshin Dowlati (6 shared papers)S. Savage (5 shared papers)Mohammed M. Dar (9 shared papers)Herbert I. Hurwitz (2 shared papers)Shermini Saini (1 shared paper)D. Gibson (1 shared paper)
- Journals
- Investigational New Drugs (5 papers)Journal of Clinical Oncology (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)Clinical Cancer Research (3 papers)British Journal of Cancer (3 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
A. Benjamin Suttle
36 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 89
- Oncology 744
- Pulmonary and Respiratory Medicine 706
- Cancer Research 257
- Hematology 186
- Genetics 176
Countries citing papers authored by A. Benjamin Suttle
This map shows the geographic impact of A. Benjamin Suttle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Benjamin Suttle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Benjamin Suttle more than expected).
Fields of papers citing papers by A. Benjamin Suttle
This network shows the impact of papers produced by A. Benjamin Suttle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Benjamin Suttle. The network helps show where A. Benjamin Suttle may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Benjamin Suttle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 333 | |
| 2 | 2014 | 147 | |
| 3 | 2013 | 91 | |
| 4 | 2013 | 90 | |
| 5 | 2010 | 85 | |
| 6 | 2011 | 73 | |
| 7 | 2012 | 72 | |
| 8 | 2010 | 72 | |
| 9 | 1992 | 52 | |
| 10 | 2014 | 41 | |
| 11 | 2010 | 40 | |
| 12 | 2011 | 33 | |
| 13 | 2012 | 32 | |
| 14 | 2013 | 29 | |
| 15 | 2012 | 29 | |
| 16 | 2013 | 24 | |
| 17 | 2005 | 24 | |
| 18 | 2014 | 22 | |
| 19 | 2000 | 21 | |
| 20 | 2006 | 21 |
About A. Benjamin Suttle
A. Benjamin Suttle is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Hepatology, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer Treatment and Pharmacology (9 papers), Renal cell carcinoma treatment (8 papers), Colorectal Cancer Treatments and Studies (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), HER2/EGFR in Cancer Research (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (744 citations), Pulmonary and Respiratory Medicine (706 citations), Cancer Research (257 citations), Hematology (186 citations) and Genetics (176 citations). A. Benjamin Suttle has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Jeffrey P. Hodge, Lini Pandite, Afshin Dowlati, S. Savage, Mohammed M. Dar, Herbert I. Hurwitz, Shermini Saini, D. Gibson, Elmar M. Merkle and Kim L. R. Brouwer. Their work appears in journals such as Investigational New Drugs, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.